Home
About
- Overview
- Team
- Investors
Science
Pipeline
Partners
News & Events
Contact
Menu Menu

NRG doses first volunteers in mitochondrial ALS trial

9 January 2026

Longevity Technology

https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/3D-Brain.jpg 800 1200 Webadm https://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.png Webadm2026-01-09 08:00:502026-08-14 12:48:43NRG doses first volunteers in mitochondrial ALS trial

Terms & Conditions
Privacy Policy

NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase...44th Annual J.P. Morgan Healthcare Conference

Scroll to top